Whereas the presence of a single VHL syndrome allele results in adequate systemic VHL activity to prevent polycythaemia, when the wild-type allele is lost the residual cellular VHL activity is unable to prevent tumorigenesis (Semenza, 2020). The gene discussed is VHL; the disease is von Hippel-Lindau disease.